Ankylosing spondylitis trials in Belgium

5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment

  Where

  Brugge, Genk, Gent, Liège, Mons

  People

  339 worldwide

  Run by

  Novartis Pharma AG

  See details and how to joinNCT04638647 · EU 2023-504417-67-00
• Phase 1Taking people
  EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial-1)

  Where

  Gent, Leuven

  Age

  18 years and over

  People

  86 worldwide

  Run by

  Grey Wolf Therapeutics Limited

  See details and how to join2025-521315-39-00 · EU 2025-521315-39-00
• Phase 1/2Taking people
  EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)

  Where

  Ghent, Leuven

  Age

  18 years to 65 years

  People

  140 worldwide

  Run by

  Grey Wolf Therapeutics

  See details and how to joinNCT07047703
• Phase 3Taking people
  Optimizing treatment strategy in axial spondyloarthritis by molecular imaging with Technetium-labeled certolizumab pegol.

  Where

  Gent

  Age

  18 years and over

  People

  78

  Run by

  Universitair Ziekenhuis Gent

  See details and how to join2023-505694-32-00 · EU 2023-505694-32-00
• Phase 4Taking people
  A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

  Where

  Leuven, Ghent University Hospital

  Age

  18 years and over

  People

  100 worldwide

  Run by

  CARE ARTHRITIS LTD.

  See details and how to joinNCT06454188 · EU 2023-510242-24-00